Humanized mice as a model for rheumatoid arthritis.
Rüdiger Eming(Philipps University of Marburg), Grete Sønderstrup(Stanford University), S. Kanazawa(Nagoya City University), Matija Peterlin(University of California, San Francisco), Jan Meijerink, Chiyoko Sekine(Juntendo University), Kayta Kobayashi(Stanford University), Qun Chen(Stanford University), Frances Hall(MRC Weatherall Institute of Molecular Medicine), Annemieke M. H. Boots(University Medical Center Groningen), Andrew P. Cope(King's College London), Antonius W. M. Rijnders, Kevin Visconti(University of Tennessee Medical Center)
Cited by 16
Related Papers
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
|Science Translational Medicine|2013|246
Pemphigus: Current and Future Therapeutic Strategies
|Frontiers in Immunology|2019|245
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
|Journal of Clinical Investigation|1998|235
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
|Arthritis Research & Therapy|2011|212